Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Abenavoli

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Practice|September 18, 2010
Non-alcoholic fatty liver disease and pharmacological optionsL Abenavoli
Bratislavske Lekarske Listy|October 25, 2017
Celiac disease and hearing lossS Lemajic-Komazec, L Abenavoli
Minerva Medica|April 15, 2014
Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver diseaseL Abenavoli, N Milic, C Luigiano
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Elastography in hepatologyL Abenavoli, C Corpechot, R Poupon
Bratislavske Lekarske Listy|August 23, 2016
The efficacy of Mediterranean diet in non-alcoholic fatty liver diseaseL Abenavoli, L Di Renzo, A De Lorenzo
International Journal of Immunopathology and Pharmacology|February 9, 2005
Wilson's disease: clinical, genetic and pharmacological findingsL Leggio, G Addolorato, L Abenavoli, et al.
World Journal of Gastroenterology|May 1, 2007
Celiac disease and skin: psoriasis associationL Abenavoli, L Leggio, G Gasbarrini, et al.
International Journal of Clinical Practice|December 29, 2015
Pharmacotherapy of alcoholic liver disease in clinical practiceV Rosato, L Abenavoli, A Federico, et al.
European Review for Medical and Pharmacological Sciences|June 22, 2021
Efficacy and tolerability of a novel galactomannan-based formulation for symptomatic treatment of gastroesophageal reflux disease: a randomized, double-blind, placebo-controlled studyL Abenavoli, C Luigiano, R Pendlimari, et al.
European Review for Medical and Pharmacological Sciences|December 17, 2016
Ethanol concentration changes in blood samples during medium-term refrigerated storageG Stojiljkovic, M Maletin, D Stojic, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Practice|September 18, 2010
Non-alcoholic fatty liver disease and pharmacological optionsL Abenavoli
Bratislavske Lekarske Listy|October 25, 2017
Celiac disease and hearing lossS Lemajic-Komazec, L Abenavoli
Minerva Medica|April 15, 2014
Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver diseaseL Abenavoli, N Milic, C Luigiano
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Elastography in hepatologyL Abenavoli, C Corpechot, R Poupon
Bratislavske Lekarske Listy|August 23, 2016
The efficacy of Mediterranean diet in non-alcoholic fatty liver diseaseL Abenavoli, L Di Renzo, A De Lorenzo
International Journal of Immunopathology and Pharmacology|February 9, 2005
Wilson's disease: clinical, genetic and pharmacological findingsL Leggio, G Addolorato, L Abenavoli, et al.
World Journal of Gastroenterology|May 1, 2007
Celiac disease and skin: psoriasis associationL Abenavoli, L Leggio, G Gasbarrini, et al.
International Journal of Clinical Practice|December 29, 2015
Pharmacotherapy of alcoholic liver disease in clinical practiceV Rosato, L Abenavoli, A Federico, et al.
European Review for Medical and Pharmacological Sciences|June 22, 2021
Efficacy and tolerability of a novel galactomannan-based formulation for symptomatic treatment of gastroesophageal reflux disease: a randomized, double-blind, placebo-controlled studyL Abenavoli, C Luigiano, R Pendlimari, et al.
European Review for Medical and Pharmacological Sciences|December 17, 2016
Ethanol concentration changes in blood samples during medium-term refrigerated storageG Stojiljkovic, M Maletin, D Stojic, et al.
Pageof 5